{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:46:19Z","timestamp":1768365979818,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100022720","name":"Health Bureau","doi-asserted-by":"publisher","award":["21220241"],"award-info":[{"award-number":["21220241"]}],"id":[{"id":"10.13039\/100022720","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertension is the most prevalent chronic condition and is the leading cause of cardiovascular diseases, imposing enormous burdens on the healthcare system. Although telemedicine may provide improved blood pressure (BP) monitoring and control, it remains unclear whether it could replace face-to-face consultations for patients with optimal BP control. Thus, the primary objective of this study is to investigate whether participants assigned to the telemedicine group show non-inferior BP control compared to the usual care group at 12\u00a0months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This randomised controlled trial (RCT) will involve 364 patients receiving anti-HT medications who have well-controlled BP on out-of-office BP measurements, including HBPM or ambulatory blood pressure measurements (ABPM). Participants will be randomised to either the telemedicine (HealthCap) group or usual care (control) group (1:1). Patients in the intervention group will measure and transmit their 7-day home BP measurements (HBPM) to the physician\u2019s office. The medications will be refilled without consultation when optimal control (&lt;135\/85\u00a0mmHg for patients without comorbidities and &lt;130\/80\u00a0mmHg for patients with comorbidities that increase cardiovascular risk) and safety questions are confirmed. Nevertheless, if any of the answers in the safety questions are positive or the HBPM mean is suboptimal, patients will have consultations as planned. Investigators will be blinded to the randomisation sequence and allocation. The primary outcome is the daytime ABPM systolic BP at 12 months. Secondary outcomes include HT treatment adherence, self-efficacy, number of visits to primary care clinics where they have clinical follow-up, health care utilisation other than general outpatient clinics (GOPCs) in both arms at baseline, 6 months, and 12 months. Acceptability will be assessed through interviews with the telemedicine study participants and the physician.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and significance<\/jats:title>\n                    <jats:p>This trial will examine whether patients in the telemedicine group would have non-inferior BP control compared to patients in the usual care group. It has the potential to change clinical practice and have important research implications because patients with optimal BP can monitor their BP through a telemedicine system and will have fewer frequent clinical visits. This will empower primary care and allow effective and safe allocation of scarce medical resources to patients in need. Moreover, it will save patients time because of the long wait to see doctors and collect medications in GOPCs. It is also encouraging the engagement of patients in their health because they will play a proactive role in managing their chronic illnesses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov NCT06524180. Registered on July 29, 2024.\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT06524180?term=NCT06524180&amp;rank=1#more-information\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/study\/NCT06524180?term=NCT06524180&amp;rank=1#more-information<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09350-3","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T07:45:24Z","timestamp":1765179924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Can TElemedicine system replace doctor consultations to Achieve non-inferior blood pressure in patients with Controlled Hypertension (TEACH)? Study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"27","author":[{"given":"Sze Nok","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin Hon-Kei","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley Yue Kwan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuk-yun","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Jinghao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy Wing-Sze","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sum Yin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia S.","family":"Mihailidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric Kam-Pui","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"9350_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ijcard.2014.12.064","volume":"182","author":"CD Kang","year":"2015","unstructured":"Kang CD, Tsang PPM, Li WTL, Wang HHX, Liu KQL, Griffiths SM, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: a cross-sectional study. Int J Cardiol. 2015;182:250\u20137.","journal-title":"Int J Cardiol"},{"issue":"10304","key":"9350_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"B Zhou","year":"2021","unstructured":"Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957\u201380.","journal-title":"Lancet"},{"issue":"5","key":"9350_CR3","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.120.15873","volume":"76","author":"S Omboni","year":"2020","unstructured":"Omboni S, McManus RJ, Bosworth HB, Chappell LC, Green BB, Kario K, et al. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension. Hypertension. 2020;76(5):1368\u201383.","journal-title":"Hypertension"},{"issue":"10124","key":"9350_CR4","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(18)30309-X","volume":"391","author":"RJ McManus","year":"2018","unstructured":"McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949\u201359.","journal-title":"Lancet"},{"issue":"6","key":"9350_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/HYPERTENSIONAHA.118.12415","volume":"73","author":"M Monahan","year":"2019","unstructured":"Monahan M, Jowett S, Nickless A, Franssen M, Grant S, Greenfield S, et al. Cost-effectiveness of telemonitoring and self-monitoring of blood pressure for antihypertensive titration in primary care (TASMINH4). Hypertension. 2019;73(6):1231\u20139.","journal-title":"Hypertension"},{"issue":"3","key":"9350_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/HYPERTENSIONAHA.119.13273","volume":"74","author":"X Lu","year":"2019","unstructured":"Lu X, Yang H, Xia X, Lu X, Lin J, Liu F, et al. Interactive mobile health intervention and blood pressure management in adults. Hypertension. 2019;74(3):697\u2013704.","journal-title":"Hypertension"},{"issue":"9","key":"9350_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002389","volume":"14","author":"KL Tucker","year":"2017","unstructured":"Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14(9):e1002389.","journal-title":"PLoS Med"},{"issue":"1","key":"9350_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1357633X16674087","volume":"24","author":"C Scott Kruse","year":"2018","unstructured":"Scott Kruse C, Karem P, Shifflett K, Vegi L, Ravi K, Brooks M. Evaluating barriers to adopting telemedicine worldwide: a systematic review. J Telemed Telecare. 2018;24(1):4\u201312.","journal-title":"J Telemed Telecare"},{"issue":"1","key":"9350_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10916-023-01933-4","volume":"47","author":"S Wang","year":"2023","unstructured":"Wang S, Leung M, Leung S-Y, Han J, Leung W, Hui E, et al. Safety, feasibility, and acceptability of telemedicine for hypertension in primary care: a proof-of-concept and pilot randomized controlled trial (SATE-HT). J Med Syst. 2023;47(1):34.","journal-title":"J Med Syst"},{"issue":"2","key":"9350_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/jamia\/ocz175","volume":"27","author":"S Akbar","year":"2019","unstructured":"Akbar S, Coiera E, Magrabi F. Safety concerns with consumer-facing mobile health applications and their consequences: a scoping review. J Am Med Inform Assoc. 2019;27(2):330\u201340.","journal-title":"J Am Med Inform Assoc"},{"key":"9350_CR11","unstructured":"Chan A-W, Boutron I, Hopewell S, Mocher D, Schulz KF, et al. SPIRIT 2025 statement: updated guidance for protocols of randomised trials. British Medical Journal; 2025;389:e081477."},{"issue":"6","key":"9350_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/08037051.2018.1527177","volume":"27","author":"B Williams","year":"2018","unstructured":"Williams B, Giuseppe M, Wilko S, Enrico AR, Michel A, Michel B, et al. 2018 practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018;27(6):314\u201340.","journal-title":"Blood Press"},{"issue":"5","key":"9350_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jama.2019.9811","volume":"322","author":"W-Y Yang","year":"2019","unstructured":"Yang W-Y, Melgarejo JD, Thijs L, Zhang Z-Y, Boggia J, Wei F-F, et al. Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA. 2019;322(5):409\u201320.","journal-title":"JAMA"},{"key":"9350_CR14","doi-asserted-by":"crossref","unstructured":"Bo Y, Kwok K-O, Chung VC-H, Yu C-P, Tsoi KK-F, Wong SY-S, et al. Short-term reproducibility of ambulatory blood pressure measurements: a systematic review and meta-analysis of 35 observational studies. Journal of Hypertension. 2020;38(11):2095\u2013109.","DOI":"10.1097\/HJH.0000000000002522"},{"issue":"1","key":"9350_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/hr.2014.149","volume":"38","author":"M Gorostidi","year":"2015","unstructured":"Gorostidi M, Vinyoles E, Banegas JR, de la Sierra A. Prevalence of white-coat and masked hypertension in national and international registries. Hypertens Res. 2015;38(1):1\u20137.","journal-title":"Hypertens Res"},{"key":"9350_CR16","unstructured":"Primary Care Office DoH HKSG. Hypertension care for adults in primary care settings. 2018."},{"issue":"17","key":"9350_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026582","volume":"11","author":"EKP Lee","year":"2022","unstructured":"Lee EKP, Poon P, Yip BHK, Bo Y, Zhu MT, Yu CP, et al. Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: a meta\u2010analysis involving 27 million patients. J Am Heart Assoc. 2022;11(17):e026582.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"9350_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/HYPERTENSIONAHA.107.100727","volume":"51","author":"RH Fagard","year":"2008","unstructured":"Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51(1):55\u201361.","journal-title":"Hypertension"},{"issue":"9","key":"9350_CR19","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1097\/HJH.0b013e328363e964","volume":"31","author":"E O\u2019Brien","year":"2013","unstructured":"O\u2019Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731\u201368.","journal-title":"J Hypertens"},{"issue":"649","key":"9350_CR20","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.3399\/bjgp16X685717","volume":"66","author":"S Wood","year":"2016","unstructured":"Wood S, Greenfield SM, Sayeed Haque M, Martin U, Gill PS, Mant J, et al. Influence of ethnicity on acceptability of method of blood pressure monitoring: a cross-sectional study in primary care. Br J Gen Pract. 2016;66(649):e577\u201386.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"9350_CR21","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","volume":"20","author":"N Luo","year":"2017","unstructured":"Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20(4):662\u20139.","journal-title":"Value Health"},{"issue":"6","key":"9350_CR22","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1365-2648.2011.05835.x","volume":"68","author":"C Ma","year":"2012","unstructured":"Ma C, Chen S, You L, Luo Z, Xing C. Development and psychometric evaluation of the treatment adherence questionnaire for patients with hypertension. J Adv Nurs. 2012;68(6):1402\u201313.","journal-title":"J Adv Nurs"},{"issue":"1","key":"9350_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10900-011-9410-6","volume":"37","author":"J Warren-Findlow","year":"2012","unstructured":"Warren-Findlow J, Seymour RB, Brunner Huber LR. The association between self-efficacy and hypertension self-care activities among African American adults. J Community Health. 2012;37(1):15\u201324.","journal-title":"J Community Health"},{"issue":"1","key":"9350_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/0047237915596605","volume":"45","author":"E Wahesh","year":"2015","unstructured":"Wahesh E, Lewis TF. Psychosocial correlates of AUDIT-C hazardous drinking risk status: implications for screening and brief intervention in college settings. J Drug Educ. 2015;45(1):17\u201336.","journal-title":"J Drug Educ"},{"issue":"7","key":"9350_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15071553","volume":"15","author":"A Chang","year":"2018","unstructured":"Chang A, Schulz PJ. The measurements and an elaborated understanding of Chinese eHealth literacy (C-eHEALS) in chronic patients in China. Int J Environ Res Public Health. 2018;15(7):1553.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"9350_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s11606-017-4000-7","volume":"32","author":"P Makai","year":"2017","unstructured":"Makai P, IntHout J, Deinum J, Jenniskens K, Wilt GJvd. A network meta-analysis of clinical management strategies for treatment-resistant hypertension: making optimal use of the evidence. J Gen Intern Med. 2017;32(8):921\u201330.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"9350_CR27","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1097\/HJH.0000000000003229","volume":"40","author":"EK-P Lee","year":"2022","unstructured":"Lee EK-P, Zhu M, Chan DC-C, Yip BH-K, Mihailidou AS, Wong SY-S. Comparing effect of definition of diurnal periods by diary, fixed periods, and actigraphy on ambulatory blood pressure parameters in a Chinese population. J Hypertens. 2022;40(9):1815\u201321.","journal-title":"J Hypertens"},{"issue":"2","key":"9350_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"6","key":"9350_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09350-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:05:50Z","timestamp":1768341950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09350-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9350"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09350-3","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial has been reviewed and approved by the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee (2023.525) and Institutional Review Board of the University of Hong Kong\/Hospital Authority Hong Kong West Cluster (UW25-086). The evaluator will explain the informed consent to the participants thoroughly. Before giving informed consent, the participants will have time to consider and ask the evaluator questions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}